3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer -

European study supports hair dye-lymphoma link

CancerJul 04, 06

Using hair dye may increase the risk of a type of cancer known as lymphoma, a European study shows.

“Our data suggest that personal use of hair coloring is associated with a small increase in lymphoma risk, particularly among women who started using hair coloring products before 1980,” Dr. Silvia de Sanjose of the Catalan Institute of Oncology in Barcelona and colleagues write in the July 1 issue of the American Journal of Epidemiology.

Past research has suggested a link between coloring one’s hair and lymphoma risk, de Sanjose and her team note. They sought to investigate the association by analyzing results from a large study of lymphoma patients and matched healthy controls, including a total of 4,719 people from six European countries. About three quarters of women reported using hair dye, while 7 percent of men did.

The researchers found an overall 19 percent increased risk of lymphoma among people who reported coloring their hair. The increased risk was 26 percent among those who used hair dye 12 or more times a year.

People who began coloring their hair before 1980 showed a 37 percent increased lymphoma risk, while those who had only dyed their hair before 1980, but not afterwards, showed a 62 percent increased risk.

Based on the findings, de Sanjose and her team calculate that roughly 10 percent of lymphomas in women could be due to the use of hair dye.

From 1978 to 1982, the researchers note, the ingredients of certain types of dyes were changed to eliminate some potentially cancer-causing agents. But it is not clear whether the newer dyes are risk-free. Clearly, more research is needed, they conclude.

SOURCE: American Journal of Epidemiology, July 1, 2006.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site